首頁 > 市場調查報告書 > 航空與太空

市場調查報告書

商品編碼

1392048

抗輻射藥物市場：依適應症、給藥途徑、配銷通路及地區分類

Anti-Radiation Drugs Market, By Indication, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2023年11月01日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2023年全球抗輻射藥物市場規模為5.874億美元，2030年預計將達9.31億美元，2023年至2030年年複合成長率為6.8%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	5.874 億美元
實績資料	2018-2021	預測期	2023-2030
預測期年複合成長率	6.80%	2030年市場規模預測	9.31億美元

圖 1. 2023 年按地區分類的抗輻射藥物全球市場佔有率(%)

抗輻射藥物是用來對抗輻射暴露對人體產生的負面影響的藥物。近年來，抗輻射藥物的需求不斷增加，因為長期暴露於電離輻射會對身體產生有害影響，導致放射病、癌症、基因突變等各種健康問題。

這些藥物的作用是保護人體細胞和 DNA 免受輻射的有害影響。抗輻射劑可降低輻射引起的疾病的風險並提高輻射暴露個體的生存率。抗輻射劑可用作在涉及輻射暴露的行業工作的人員以及生活在易受自然輻射的地區的人員的預防措施。

市場動態：

預計全球抗輻射藥物市場在不久的將來將出現顯著成長。癌症盛行率的增加以及癌症治療中放射線治療的日益採用推動了市場的成長。核能發電廠的增加以及潛在的輻射洩漏風險將進一步推動抗輻射藥物的需求。

也存在一些限制市場成長的因素。其中包括抗輻射藥物的高成本以及藥物核准的嚴格監管要求。此外，醫療保健專業人員和一般民眾對抗輻射劑的可用性和益處缺乏認知也可能阻礙市場成長。

儘管面臨挑戰，但市場仍存在許多成長機會。人們對研發活動的投資不斷增加，以開發新的和改進的抗輻射藥物，預計將在市場上創造機會。對個人化醫療的需求不斷成長以及對精準醫療的日益關注預計將推動市場成長。

本研究的主要特點

本報告對全球抗輻射藥物市場進行了詳細分析，包括以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率。
它還揭示了各個細分市場的潛在商機，並說明了有吸引力的投資提案。
它提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
根據公司亮點、產品系列、財務實績和策略等參數，對全球抗輻射藥物市場的主要企業進行了分析。
本報告中包含的知名公司包括 Amgen Inc.、Partner Therapeutics Inc.、RedHill Biopharma Ltd.、Humanetics Corporation、RxBio Inc.、Soligenix Inc.、Aeolus Pharmaceuticals、Onconova Therapeutics、Genome Protection Inc.。
該報告的見解使行銷人員和負責人能夠就產品發布、升級、市場擴張和行銷策略做出資訊的決策。
本報告針對產業內的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以從用於分析全球抗輻射藥物市場的各種策略矩陣中受益，以促進決策。

介紹
北美洲
美國
加拿大
歐洲
英國
德國
義大利
法國
西班牙
俄羅斯
歐洲其他地區
亞太地區
中國
印度
日本
東南亞國協
澳洲
韓國
其他亞太地區
拉丁美洲
巴西
墨西哥
阿根廷
其他拉丁美洲
中東
海灣合作理事會國家
以色列
其他中東地區
非洲
北非
中部非洲
南非

第9章競爭形勢

Amgen Inc.
Partner Therapeutics Inc.
RedHill Biopharma Ltd.
Humanetics Corporation
RxBio Inc.
Soligenix Inc.
Aeolus Pharmaceuticals
Onconova Therapeutics
Genome Protection Inc.

第10章

調查方法
關於出版商

簡介目錄

Product Code: CMI6418

Global Anti-Radiation Drugs Market size is expected to be valued at US$ 587.4 Mn in 2023, and is expected to reach US$ 931 Mn by 2030, exhibiting a compound annual growth rate (CAGR) of 6.8% from 2023 to 2030.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 587.4 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	6.80%	2030 Value Projection:	US$ 931 Mn

Figure 1. Global Anti-Radiation Drugs Market Share (%), By Region, 2023

Anti-radiation drugs are pharmaceutical medications that are used to combat the harmful effects of radiation exposure in humans. Prolonged exposure to ionizing radiation can have detrimental effects on the body that leads to various health issues such as radiation sickness, cancer, and genetic mutations, and this has boosted demand for anti-radiation drugs in recent years.

These drugs work by protecting the body's cells and DNA from the damaging effects of radiation. These aid in reducing the risk of radiation-induced illnesses and improving the chances of survival for individuals exposed to radiation. Anti-radiation drugs can be used as preventive measures for people working in industries that involve radiation exposure, as well as for individuals in areas prone to natural radiation.

Market Dynamics:

Global anti-radiation drugs market is projected to witness significant growth in the near future. The market growth is driven by increasing prevalence of cancer and growing adoption of radiation therapy in cancer treatment. Rising number of nuclear power plants, along with the potential risk of radiation leaks, further boosts demand for anti-radiation drugs.

There are certain factors that may restrain the market growth. These include the high cost of anti-radiation drugs and the stringent regulatory requirements for drug approval. Moreover, the lack of awareness about the availability and benefits of these drugs among healthcare professionals and the general population could hinder market growth.

Despite the challenges, the market presents numerous opportunities for growth. Increasing investment in research and development activities to develop new and improved anti-radiation drugs expected to offer opportunity to the market. Rising demand for personalized medicine and growing focus on precision healthcare are expected to drive the market growth.

Key Features of the Study:

This report provides in-depth analysis of the global anti-radiation drugs market, including market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), with 2022 as the base year
It elucidates potential revenue opportunities across different market segments and explains attractive investment propositions
The study provides key insights into market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and the competitive strategies adopted by key players
Key players in the global anti-radiation drugs market are profiled based on parameters such as company highlights, product portfolio, financial performance, and strategies
The report includes prominent companies such as Amgen Inc., Partner Therapeutics Inc., RedHill Biopharma Ltd., Humanetics Corporation, RxBio Inc., Soligenix Inc., Aeolus Pharmaceuticals, Onconova Therapeutics, and Genome Protection Inc.
Insights from this report will enable marketers and management authorities to make informed decisions regarding product launches, upgrades, market expansion, and marketing tactics
The report caters to various stakeholders in the industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders can benefit from the various strategy matrices used in analyzing the global anti-radiation drugs market, facilitating ease in decision-making

Anti-Radiation Drugs Market Detailed Segmentation:

By Indication
- Acute Radiation Syndrome
- Delayed Radiation Syndrome
By Route of Administration
- Oral
- Intramuscular
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Amgen Inc.
- Partner Therapeutics Inc.
- RedHill Biopharma Ltd.
- Humanetics Corporation
- RxBio Inc.
- Soligenix Inc.
- Aeolus Pharmaceuticals
- Onconova Therapeutics
- Genome Protection Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Indication
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing incidence of cancer globally
Growing threat of nuclear accidents and events
Favorable regulatory environment for drug development
Technological advancements in drug delivery systems
- Restraints
- Opportunities
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Anti-Radiation Drugs Market- Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Anti-Radiation Drugs Market, By Indication, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Acute Radiation Syndrome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Delayed Radiation Syndrome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

6. Global Anti-Radiation Drugs Market, By Route of Administration, 2023-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018- 2030
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

7. Global Anti-Radiation Drugs Market, By Distribution Channel, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

8. Global Anti-Radiation Drugs Market, By Region, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Mn)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Partner Therapeutics Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
RedHill Biopharma Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Humanetics Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
RxBio Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Soligenix Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Aeolus Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Onconova Therapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Genome Protection Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views